International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10070715
Original Article
Diagnostic Utility of Bronchoalveolar Lavage Fluid in Cases of Tuberculosis
 ,
 ,
 ,
 ,
Published
Oct. 31, 2023
Abstract

This article explores the clinical features and  diagnostic utility of bronchoalveolar lavage associated with tuberculosis.Early diagnosis of pulmonary tuberculosis (PTB) is essential to reduce the spread, morbidity, mortality, and escalating costs associated with advanced disease.In this article 45 cases of tuberculosis are presented, highlighting the role of bronchoalveolar lavage . Mycobacterial culture is considered gold standard but time taken for results is 2-6 weeks. Bronchoalveolar lavage (BAL) is a safe, minimally invasive and inexpensive diagnostic technique commonly used to obtain cells, infectious agents and noncellular elements from the lower respiratory tract in patients with bilateral diffuse lung diseases.Bal fluid sample is also being used for applying Gene Xpert for MTB in our hospital sectors. Evaluation FOB/BAL is a useful diagnostic tool, and seems to have changed the course of therapy in more than half of patients, by initiation or cessation of treatment.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
1689 Views
343 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved